InMed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1,120 | $1,777 | $1,261 | $1,111 |
Gross Profit | 403 | 785 | 175 | 460 |
EBITDA | -1,570 | -2,437 | -1,991 | -2,094 |
EBIT | -1,726 | -2,509 | -2,120 | -2,223 |
Net Income | -1,726 | -2,435 | -2,120 | -2,575 |
Net Change In Cash | 1,120 | 1,777 | 1,261 | 1,111 |
Free Cash Flow | -1,607 | -1,778 | -1,659 | -2,502 |
Cash | 9,331,077 | 11,075 | 4,679 | 3,419 |
Basic Shares | 3 | 2,002 | 1,095 | 706 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $4,942 | $4,597 | $4,135 | $1,089 |
Gross Profit | 1,706 | 1,100 | 1,403 | 543 |
EBITDA | -7,255 | -7,063 | -7,782 | -13,279 |
EBIT | -7,790 | -7,668 | -8,378 | -13,791 |
Net Income | -8,162 | -7,675 | -7,947 | -18,600 |
Net Change In Cash | 4,942 | 4,597 | 4,135 | 1,089 |
Free Cash Flow | -7,766 | -6,995 | -7,445 | -15,622 |
Cash | 11,075 | 6,571 | 8,912 | 7,951 |
Basic Shares | 975 | 381 | 122 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.43 |
2025-06-30 | -$1.20 |
2025-03-31 | -$1.93 |
2024-12-31 | -$3.64 |
